Integrative metabolomics and gene expression analyses reveal acetogenin-rich annona muricata leaf extract suppresses MCF-7 cell proliferation in obesogenic microenvironment
Year: 2026
Type: article
Abstract: Obesity is associated with a significantly poorer prognosis in patients with Luminal A breast cancer, this investigation sought to determine the growth-inhibitory potential of Annona muricata leaf extracts against MCF-7 cells under obesogenic conditions and to identify key bioactive compounds through integrative metabolomics, gene expression analysis, and molecular docking. MCF-7 cells cultured in an obesogenic microenvironment were treated with 96, 75, and 25% ethanol extracts of A. muricata leaves. Antiproliferative assay was determined by IC₅₀ values. Expression of BAX and E2F2 was analysed to assess apoptotic and proliferative responses. Metabolomic profiling was executed via LC-MS/MS, with subsequent multivariate statistical tools—specifically PCA and PLS regression—employed to identify correlations between specific metabolites, IC₅₀ data, and gene expression patterns. Selected metabolites were evaluated by molecular docking against MDM2 (PDB ID: 1T4E). The 96% ethanol extract exhibited the strongest antiproliferative activity (IC₅₀ = 1.671 µg/mL). All extracts upregulated BAX, particularly the 75% extract, while E2F2 was downregulated in the 25 and 96% extracts. LC–MS/MS identified 339 annotated metabolites with clear PCA clustering. The PLS model showed excellent predictive performance (R²Y = 0.9897; Q²-cum = 0.9762; RMSEE = 0.0541). Metabolites at retention times 24–40 min with VIP 1 were mainly acetogenins, including muricatocin A and chatenaytrienin 1, negatively correlated with IC₅₀ and associated with increased BAX and decreased E2F2. Docking analysis showed stronger binding affinities than the native ligand. Acetogenin-rich A. muricata extract demonstrates potent antiproliferative activity under obesogenic conditions, potentially through inhibition of the MDM2–p53 interaction and modulation of apoptotic and proliferative pathways.
Source: Scientific Reports
Language: English
Subfield: Biochemistry
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $2,690
Award: G9001386574
OpenAlex ID: W7234013585
